Vericel PE ratio VCEL

Share price divided by earnings per share over the last twelve months, since 2021.

Today, Oct 23, 2026: 92.5×
5-year median: 158×
Against its 5-year history: 16th; percentile: 0 is its lowest day, 100 its highest
5-year range: 80.6× to 313×
Peer median: 29.2×

Vericel's PE ratio is 92.5× as of Oct 23, 2026: a share price of $42.53 against $0.46 of earnings per share over the last twelve months.

That is below its 5-year median of 158×, lower than on 84% of days in the last 5 years.

Over that time it ranged from 80.6× in May 2026 to 313× in Sep 2021.

The median for 8 biotech stocks of a similar size is 29.2×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	92.5×	80.6×	161×
2025	157×	150×	309×
2024	n/m a value too high to mean anything
2023	n/m a value too high to mean anything
2022	n/m a value too high to mean anything
2021	256×	256×	313×

Against its peers

Companies in Biotechnology nearest Vericel's size, closest first, today.

Company	PE ratio
VCELVericel	92.5×
ADMAAdma Biologics	15.3×
MGTXMeiraGTx	13.0×
KRYSKrystal Biotech	39.0×
RGENRepligen	242×
TECHBIO-TECHNE	63.1×
HALOHalozyme Therapeutics	37.5×
NBIXNeurocrine Biosciences	20.9×
EXELExelixis	20.3×
Peer median	29.2×

Where Vericel ranks

#15of 16Biotech stocks with the lowest PE ratio

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Vericel

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.